$0.8634
-0.0066-0.76%
Last update: Nov 5, 10:35 AM

The average analyst price target for Organogenesis Holdings is $6, 594.9% above the current price. Of 4 analysts, 3 rate it Buy and 1 Hold. Targets range from $2 to $9. The latest change came on Aug 7, 2026, when Truist Securities lowered its price target on Organogenesis Holdings from $3 to $2 and kept a Hold rating.
Price Target Range — 9 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months